Status: current, Defined. Date: 31-Aug 2013. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
630591000036116 | Candesartan/HCT 32 mg/12.5 mg (Sandoz) (candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg) tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
630601000036111 | Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30 | Is a | candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet, 30 | true | Inferred relationship | Some | ||
Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30 | has TPUU | Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | true | Inferred relationship | Some | 1 | |
Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30 | has TP | Candesartan/HCT 32 mg/12.5 mg (Sandoz) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30, blister pack | Is a | True | Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30 | Inferred relationship | Some | |
Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30, bottle | Is a | True | Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30 | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Trade product pack reference set